Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application

Kang, 2015, Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment, Acta Pharm Sin B, 5, 169, 10.1016/j.apsb.2015.03.001 Weng, 2017, Nanotechnology-based strategies for treatment of ocular disease, Acta Pharm Sin B, 7, 281, 10.1016/j.apsb.2016.09.001 Fang, 2012, Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors, Cancer Sci, 103, 535, 10.1111/j.1349-7006.2011.02178.x Iwamoto, 2013, Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs, Biol Pharm Bull, 36, 715, 10.1248/bpb.b12-01102 Chen, 2016, Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy, ACS Nano, 10, 93, 10.1021/acsnano.5b05043 Veronese, 2005, PEGylation, successful approach to drug delivery, Drug Discov Today, 10, 1451, 10.1016/S1359-6446(05)03575-0 Harris, 2003, Effect of pegylation on pharmaceuticals, Nat Rev Drug Discov, 2, 214, 10.1038/nrd1033 Luk, 2016, Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors, Theranostics, 6, 1004, 10.7150/thno.14471 Rao, 2016, Cancer cell membrane-coated upconversion nanoprobes for highly specific tumor imaging, Adv Mater, 28, 3460, 10.1002/adma.201506086 Jin, 2018, Biomimetic nanoparticles for inflammation targeting, Acta Pharm Sin B, 8, 23, 10.1016/j.apsb.2017.12.002 Ha, 2016, Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges, Acta Pharm Sin B, 6, 287, 10.1016/j.apsb.2016.02.001 Huang, 2018, Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy, Acta Pharm Sin B, 8, 4, 10.1016/j.apsb.2017.12.001 Ihler, 1973, Enzyme loading of erythrocytes, Proc Natl Acad Sci U S A, 70, 2663, 10.1073/pnas.70.9.2663 Pierigè, 2008, Cell-based drug delivery, Adv Drug Deliv Rev, 60, 286, 10.1016/j.addr.2007.08.029 Hamidi, 2003, Carrier erythrocytes: an overview, Drug Deliv, 10, 9, 10.1080/713840329 Patel, 2008, Drug loaded erythrocytes: as novel drug delivery system, Curr Pharm Des, 14, 63, 10.2174/138161208783330772 Dehaini, 2017, Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization, Adv Mater, 29, 1606209, 10.1002/adma.201606209 Yoo, 2011, Bio-inspired, bioengineered and biomimetic drug delivery carriers, Nat Rev Drug Discov, 10, 521, 10.1038/nrd3499 Wang, 2014, Multifunctional theranostic red blood cells for magnetic-field-enhanced in vivo combination therapy of cancer, Adv Mater, 26, 4794, 10.1002/adma.201400158 Sun, 2016, Remotely controlled red blood cell carriers for cancer targeting and near-infrared light-triggered drug release in combined photothermal-chemotherapy, Adv Funct Mater, 12, 548 Doshi, 2009, Red blood cell-mimicking synthetic biomaterial particles, Proc Natl Acad Sci U S A, 106, 21495, 10.1073/pnas.0907127106 Tsai, 2010, Self inhibition of phagocytosis: the affinity of ׳marker of self׳ CD47 for SIRP alpha dictates potency of inhibition but only at low expression levels, Blood Cells Mol Dis, 45, 67, 10.1016/j.bcmd.2010.02.016 Merkel, 2011, Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles, Proc Natl Acad Sci U S A, 108, 586, 10.1073/pnas.1010013108 Marsden, 1959, Accumulation of dextran in human red cells after haemolysis, Nature, 184, 723, 10.1038/184723a0 Jain, 1997, Engineered erythrocytes as a drug delivery system, Indian J Pharm Sci, 59, 275 Hu, 2012, Erythrocyte-inspired delivery systems, Adv Healthc Mater, 1, 537, 10.1002/adhm.201200138 Lejeune, 1994, Nanoerythrosome, a new derivative of erythrocyte ghost: preparation and antineoplastic potential as drug carrier for daunorubicin, Anticancer Res, 14, 915 Desilets, 2001, Nanoerythrosomes, a new derivative of erythrocyte ghost: iv. Fate of reinjected nanoerythrosomes, Anticancer Res, 21, 1741 Hu, 2013, A biomimetic nanosponge that absorbs pore-forming toxins, Nat Nanotechnol, 8, 336, 10.1038/nnano.2013.54 Brown, 2001, Integrin-associated protein (CD47): an unusual activator of G protein signaling, J Clin Investig, 107, 1499, 10.1172/JCI13315 Oldenborg, 2000, Role of CD47 as a marker of self on red blood cells, Science, 288, 2051, 10.1126/science.288.5473.2051 Barclay, 2014, The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target, Annu Rev Immunol, 32, 25, 10.1146/annurev-immunol-032713-120142 Kroll, 2017, Biointerfacing and applications of cell membrane-coated nanoparticles, Bioconjug Chem, 28, 23, 10.1021/acs.bioconjchem.6b00569 Schonermark, 1986, Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor, J Immunol, 136, 1772, 10.4049/jimmunol.136.5.1772 Zalman, 1986, Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels, Proc Natl Acad Sci U S A, 83, 6975, 10.1073/pnas.83.18.6975 Kim, 2008, Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg, Blood, 112, 1109, 10.1182/blood-2008-01-134304 Fang, 2012, Nanoparticles disguised as red blood cells to evade the immune system, Expert Opin Biol Ther, 12, 385, 10.1517/14712598.2012.661710 Hu, 2011, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform, Proc Natl Acad Sci U S A, 108, 10980, 10.1073/pnas.1106634108 Ihler, 1987, Hypotonic hemolysis methods for entrapment of agents in resealed erythrocytes, MethodsEnzymol, 149, 221 Sato, 1993, Mechanism of hypotonic hemolysis of human erythrocytes, Biol Pharm Bull, 16, 506, 10.1248/bpb.16.506 Seth, 2010, Dilution technique to determine the hydrodynamic volume fraction of a vesicle suspension, Langmuir, 26, 15169, 10.1021/la1023086 Bird, 1983, The encapsulation of insulin in erythrocytes, J Pharm Pharmacol, 35, 246, 10.1111/j.2042-7158.1983.tb02921.x Gutierrez, 2004, Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis, Blood Cells Mol Dis, 33, 132, 10.1016/j.bcmd.2004.06.004 Tajerzadeh, 2000, Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes, Drug Dev Ind Pharm, 26, 1247, 10.1081/DDC-100102306 Hamidi, 2007, Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-α2b, Int J Pharm, 341, 125, 10.1016/j.ijpharm.2007.04.001 Franco, 1986, Effect of inositol hexaphosphate on the transient behavior of red cells following a DMSO-induced osmotic pulse, J Cell Physiol, 129, 221, 10.1002/jcp.1041290214 Watts, 2007, The haemolytic effect of verapamil on erythrocytes exposed to varying osmolarity, Toxicol Vitr, 21, 835, 10.1016/j.tiv.2007.02.002 Lynch, 2011, pH-responsive polymers for trehalose loading and desiccation protection of human red blood cells, Biomaterials, 32, 4443, 10.1016/j.biomaterials.2011.02.062 Choi, 2010, An electrically active microneedle array for electroporation, Biomed Microdevices, 12, 263, 10.1007/s10544-009-9381-x Ren, 2016, Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy, Biomaterials, 92, 13, 10.1016/j.biomaterials.2016.03.026 Zhai, 2017, Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy, Theranostics, 7, 2575, 10.7150/thno.20118 Hu, 2015, Nanoparticle biointerfacing by platelet membrane cloaking, Nature, 526, 118, 10.1038/nature15373 Su, 2016, Long circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer, Adv Funct Mater, 26, 1243, 10.1002/adfm.201504780 Schauer, 2009, Sialic acids as regulators of molecular and cellular interactions, Curr Opin Struct Biol, 19, 507, 10.1016/j.sbi.2009.06.003 Kelm, 1997, Sialic acids in molecular and cellular interactions, Int Rev Cytol, 175, 137, 10.1016/S0074-7696(08)62127-0 Raveendran, 2003, Completely “green” synthesis and stabilization of metal nanoparticles, J Am Chem Soc, 125, 13940, 10.1021/ja029267j Lemarchand, 2004, Polysaccharide-decorated nanoparticles, Eur J Pharm Biopharm, 58, 327, 10.1016/j.ejpb.2004.02.016 Luk, 2014, Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles, Nanoscale, 6, 2730, 10.1039/C3NR06371B Hu, 2013, ‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approach, Nanoscale, 5, 2664, 10.1039/c3nr00015j Rao, 2017, Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy, ACS Nano, 11, 3496, 10.1021/acsnano.7b00133 Miyazaki, 2002, Gene transfer into muscle by electroporation in vivo, Methods Mol Med, 69, 49 Zhang, 2015, Synthesis of nanogels via cell membrane-templated polymerization, Small, 11, 4309, 10.1002/smll.201500987 Hochmuth, 1983, Mechanical measurement of red cell membrane thickness, Science, 220, 101, 10.1126/science.6828875 Zhou, 2016, A facile approach to functionalize cell membrane-coated nanoparticles, Theranostics, 6, 1012, 10.7150/thno.15095 Gagneux, 1999, Evolutionary considerations in relating oligosaccharide diversity to biological function, Glycobiology, 9, 747, 10.1093/glycob/9.8.747 Rodriguez, 2013, Minimal “Self” peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles, Science, 339, 971, 10.1126/science.1229568 Richards, 2016, Membrane protein mobility and orientation preserved in supported bilayers created directly from cell plasma membrane blebs, Langmuir, 32, 2963, 10.1021/acs.langmuir.5b03415 Kimmett, 2014, ProBLM web server: protein and membrane placement and orientation package, Comput Math Methods Med, 2014, 838259, 10.1155/2014/838259 Wang, 2017, Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion, Biomaterials, 143, 130, 10.1016/j.biomaterials.2017.08.004 Sinha, 2004, Poly-epsilon-caprolactone microspheres and nanospheres: an overview, Int J Pharm, 278, 1, 10.1016/j.ijpharm.2004.01.044 Piao, 2014, Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy, ACS Nano, 8, 10414, 10.1021/nn503779d Fang, 2014, Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery, Nano Lett, 14, 2181, 10.1021/nl500618u Aryal, 2013, Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release, Nanomed (Lond), 8, 1271, 10.2217/nnm.12.153 Su, 2016, Bioinspired nanoparticles with NIR-controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer, Adv Funct Mater, 26, 7495, 10.1002/adfm.201603381 Zha, 2013, Biocompatible polypyrrole nanoparticles as a novel organic photoacoustic contrast agent for deep tissue imaging, Nanoscale, 5, 4462, 10.1039/c3nr00627a Jin, 2014, Encapsulating tantalum oxide into polypyrrole nanoparticles for X-ray CT/photoacoustic bimodal imaging-guided photothermal ablation of cancer, Biomaterials, 35, 5795, 10.1016/j.biomaterials.2014.03.086 Li, 2015, Magneto-optical nanoparticles for cyclic magnetomotive photoacoustic imaging, ACS Nano, 9, 1964, 10.1021/nn5069258 Martinive, 2006, Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery, Mol Cancer Ther, 5, 1620, 10.1158/1535-7163.MCT-05-0472 Sonveaux, 2004, Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment, Cancer Res, 64, 3209, 10.1158/0008-5472.CAN-03-1291 Shive, 2012, Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv Drug Deliv Rev, 64, 5 Hamid, 2018, Preparation and optimization of surface-engineered poly(lactic acid) microspheres as a drug delivery device, J Mater Sci, 53, 4745, 10.1007/s10853-017-1840-9 Tawakkal, 2014, A review of poly(lactic acid)-based materials for antimicrobial packaging, J Food Sci, 79, 1477, 10.1111/1750-3841.12534 Aryal, 2010, Polymer–cisplatin conjugate nanoparticles for acid-responsive drug delivery, ACS Nano, 4, 251, 10.1021/nn9014032 Gao, 2010, pH-Responsive nanoparticles for drug delivery, Mol Pharm, 7, 1913, 10.1021/mp100253e McCall, 2013, PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS, J Vis Exp, 51015 Alshamsan, 2014, Nanoprecipitation is more efficient than emulsion solvent evaporation method to encapsulate cucurbitacin I in PLGA nanoparticles, Saudi Pharm J, 22, 219, 10.1016/j.jsps.2013.12.002 Lin, 2013, The preparation and characteristic of poly(lactide-co-glycolide) microspheres as novel antigen delivery systems, Int J Nanotechnol, 10, 870, 10.1504/IJNT.2013.058116 Xing, 2016, Ultrasound-mediated microbubble destruction (UMMD) facilitates the delivery of CA19-9 targeted and paclitaxel loaded mPEG-PLGA-PLL nanoparticles in pancreatic cancer, Theranostics, 6, 1573, 10.7150/thno.15164 Axelson, 2005, Hypoxia-induced dedifferentiation of tumor cells—a mechanism behind heterogeneity and aggressiveness of solid tumors, Semin Cell Dev Biol, 16, 554, 10.1016/j.semcdb.2005.03.007 Vaupel, 2004, Tumor microenvironmental physiology and its implications for radiation oncology, Semin Radiat Oncol, 14, 198, 10.1016/j.semradonc.2004.04.008 Riess, 2001, Oxygen carriers (“blood substitutes”)—raison d׳etre, chemistry, and some physiology, Chem Rev, 101, 2797, 10.1021/cr970143c Castro, 2010, Perfluorocarbon-based oxygen carriers: review of products and trials, Artif Organs, 34, 622 Ren, 2017, Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy, Acta Biomater, 59, 269, 10.1016/j.actbio.2017.06.035 Gao, 2017, Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy, Adv Mater, 29, 1701429, 10.1002/adma.201701429 Zhang, 2017, Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment, Int J Nanomed, 12, 1593, 10.2147/IJN.S127256 Gao, 2017, Erythrocyte membrane-wrapped pH sensitive polymeric nanoparticles for non-small cell lung cancer therapy, Bioconjug Chem, 28, 2591, 10.1021/acs.bioconjchem.7b00428 Guo, 2015, Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma, ACS Nano, 9, 6918, 10.1021/acsnano.5b01042 Hao, 2010, Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles, Adv Mater, 22, 2729, 10.1002/adma.201000260 Sharifi, 2015, Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging, Contrast Media Mol Imaging, 10, 329, 10.1002/cmmi.1638 Yoshida, 2016, (Invited) Biological applications of magnetic nanoparticles for magnetic immunoassay and magnetic particle imaging, ECS Trans, 75, 39, 10.1149/07502.0039ecst Rao, 2015, Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance, Small, 11, 6225, 10.1002/smll.201502388 Owens, 2006, Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, Int J Pharm, 307, 93, 10.1016/j.ijpharm.2005.10.010 Chu, 2013, Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles, Biomaterials, 34, 4078, 10.1016/j.biomaterials.2013.01.086 Chen, 2014, Highly crystallized iron oxide nanoparticles as effective and biodegradable mediators for photothermal cancer therapy, J Mater Chem B, 2, 757, 10.1039/C3TB21338B Shen, 2015, Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation, Biomaterials, 39, 67, 10.1016/j.biomaterials.2014.10.064 Ding, 2015, Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer, Nanoscale, 7, 9806, 10.1039/C5NR02470F Zhou, 2018, Mesoporous silica nanoparticles for drug and gene delivery, Acta Pharm Sin B, 8, 165, 10.1016/j.apsb.2018.01.007 Su, 2017, Enhanced blood suspensibility and laser-activated rumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes, Theranostics, 7, 523, 10.7150/thno.17259 Vernier, 2009, Electroporating fields target oxidatively damaged areas in the cell membrane, PloS One, 4, e7966, 10.1371/journal.pone.0007966 Cheng, 2011, Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy, Angew Chem Int Ed Engl, 50, 7385, 10.1002/anie.201101447 Yang, 2013, Luminescent chemodosimeters for bioimaging, Chem Rev, 113, 192, 10.1021/cr2004103 Yang, 2014, Ultra-small BaGdF5-based upconversion nanoparticles as drug carriers and multimodal imaging probes, Biomaterials, 35, 2011, 10.1016/j.biomaterials.2013.11.018 Rieffel, 2015, Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles, Adv Mater, 27, 1785, 10.1002/adma.201404739 Chen, 2015, Upconversion nanoprobes for efficiently in vitro imaging reactive oxygen species and in vivo diagnosing rheumatoid arthritis, Biomaterials, 39, 15, 10.1016/j.biomaterials.2014.10.066 Zhang, 2010, Fabrication of Ag@SiO2@Y2O3:Er nanostructures for bioimaging: tuning of the upconversion fluorescence with silver nanoparticles, J Am Chem Soc, 132, 2850, 10.1021/ja909108x Li, 2018, Synergizing upconversion nanophotosensitizers with hyperbaric oxygen to remodel the extracellular matrix for enhanced photodynamic cancer therapy, ACS Appl Mater Interfaces, 10, 22985, 10.1021/acsami.8b07090 Giljohann, 2010, Gold nanoparticles for biology and medicine, Angew Chem Int Ed Engl, 49, 3280, 10.1002/anie.200904359 Dreaden, 2012, The golden age: gold nanoparticles for biomedicine, Chem Soc Rev, 41, 2740, 10.1039/C1CS15237H Moon, 2011, A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release, J Am Chem Soc, 133, 4762, 10.1021/ja200894u Pan, 2014, MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression, Adv Mater, 26, 6742, 10.1002/adma.201402752 Farokhzad, 2006, Nanomedicine: developing smarter therapeutic and diagnostic modalities, Adv Drug Deliv Rev, 58, 1456, 10.1016/j.addr.2006.09.011 Toth, 2012, Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography, Methods Mol Biol, 878, 121, 10.1007/978-1-61779-854-2_8 Li, 2014, Core-shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery, ACS Nano, 8, 4975, 10.1021/nn501040h Bose, 2018, Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics, Drug Discov Today, 23, 891, 10.1016/j.drudis.2018.02.001 Davis, 2008, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat Rev Drug Discov, 7, 771, 10.1038/nrd2614 Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat Nanotechnol, 2, 751, 10.1038/nnano.2007.387 Wagner, 2006, The emerging nanomedicine landscape, Nat Biotechnol, 24, 1211, 10.1038/nbt1006-1211 Zhang, 2008, Nanoparticles in medicine: therapeutic applications and developments, Clin Pharmacol Ther, 83, 761, 10.1038/sj.clpt.6100400 Remant, 2012, pH and redox dual responsive nanoparticle for nuclear targeted drug delivery, Mol Pharm, 9, 2719, 10.1021/mp300274g Bartczak, 2011, Preparation of peptide-functionalized gold nanoparticles using one pot EDC/Sulfo-NHS coupling, Langmuir, 27, 10119, 10.1021/la2022177 Chen, 2012, One-step facile surface engineering of hydrophobic nanocrystals with designer molecular recognition, J Am Chem Soc, 134, 13164, 10.1021/ja304115q Hu, 2010, Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells, Mol Pharm, 7, 914, 10.1021/mp900316a Jin, 2012, Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery, J Am Chem Soc, 135, 933, 10.1021/ja311180x Johnston, 2012, Targeting cancer cells: controlling the binding and internalization of antibody-functionalized capsules, ACS Nano, 6, 6667, 10.1021/nn3010476 Wang, 2010, The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies, J Am Chem Soc, 132, 11306, 10.1021/ja1043177 Fang, 2013, Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles, Nanoscale, 5, 8884, 10.1039/c3nr03064d Rao, 2017, Erythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging, ACS Appl Mater Interfaces, 9, 2159, 10.1021/acsami.6b14450 Chai, 2017, A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery, J Control Release, 264, 102, 10.1016/j.jconrel.2017.08.027 Zhu, 2018, Erythrocyte membrane-coated gold nanocages for targeted cancer photothermal and chemical therapy, Nanotechnology, 29, 084002, 10.1088/1361-6528/aa9ca1 Fu, 2015, Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane, Nanoscale, 7, 4020, 10.1039/C4NR07027E Hsieh, 2015, Biomimetic acoustically-responsive vesicles for theranostic applications, Theranostics, 5, 1264, 10.7150/thno.11848 Li, 2018, Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment, Acta Pharm Sin B, 8, 14, 10.1016/j.apsb.2017.11.009